Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis

Status unknownNot a drug-phase studyMS (type not specified)NCT03536299

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Dual-task gait

Compared with

  • Single-task gait

What it measured

Main measures

  • Change in Walking and Remembering Test

    Week 1, Week 2, Week 5, Week 8, Week 12

    Thinking and memoryWalking and mobility

Other measures (6)

  • Change in 2-Minute Walk Test

    Week 1, Week 2, Week 5, Week 8, Week 12

    Walking and mobility
  • Change in 12-Item Multiple Sclerosis Walking Scale

    Week 1, Week 2, Week 5, Week 8, Week 12

    Walking and mobility
  • Change in Fatigue Scale for Motor and Cognitive Functions

    Week 1, Week 2, Week 5, Week 8, Week 12

    Thinking and memoryFatigueQuality of life (reported by participants)
  • Change in Gait Speed

    Week 1, Week 2, Week 5, Week 8, Week 12

    Walking and mobility
  • Change in Gait Cadence

    Week 1, Week 2, Week 5, Week 8, Week 12

    Walking and mobility
  • Change in Step Length

    Week 1, Week 2, Week 5, Week 8, Week 12

    Walking and mobility

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* Ability walk independently with or without an assistive device * Independent and community-dwelling * No history or presence of other clinically significant musculoskeletal, cardiovascular, respiratory, or neurologic disease. * Definite diagnosis of MS [Expanded Disability Status Scale (EDSS) ≤6.5] * Relapse free for the past 30 days and not currently receiving or will receive any rehabilitation services during the study.

Exclusion criteria

- Participants experiencing a true relapse or exacerbation of their symptoms (>24 hours duration in the absence infection or fever, or and ambient increase in body temperature) during the study will be excluded from the study.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this study is to determine the utility of a performance measure for the dual-task of gait and considering people with multiple sclerosis have both cognitive and motor problems, the secondary aim of this study is to determine the effectiveness of a gait-specific dual-tasking intervention for ambulatory individuals with multiple sclerosis.

Loading reviews and guidelines…

History

    1. Started

      May 2018

    2. Main results due

      May 2020

    3. Finished

      May 2020

    Assembled by software from public sources.